Behnaz Eftekhari | Vascular Graft | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Behnaz Eftekhari
Scripps Health

Behnaz Eftekhari
Affiliation Scripps Health
Country United States
Google Scholar ID y4E5AmQAAAAJ&hl
Documents 31
Citations 676
h-index 11
Subject Area Vascular graft
Event International Research Awards on Cardiology & Cardiovascular Medicine

Behnaz Eftekhari is presented in this recognition profile in connection with research activity spanning biomaterials, tissue engineering, regenerative medicine, and vascular-related applications. Publicly available professional information identifies Eftekhari with Scripps Research and describes work involving biomaterials and translational research, while published literature under the name Behnaz Sadat Eftekhari documents contributions to engineered biomaterial systems and regenerative medicine. [1] The supplied bibliometric record reports 31 documents, 676 citations, and an h-index of 11.

Abstract

Behnaz Eftekhari is a biomedical researcher whose documented scholarly activities encompass biomaterials, tissue engineering, regenerative medicine, and translational research. Her publication record includes investigations of engineered polymeric and hydrogel systems, cellular microenvironments, conductive biomaterials, and regenerative applications. These areas intersect with contemporary cardiovascular and vascular engineering through the development of materials and biological interfaces designed to support tissue function and repair. Publicly available professional information also associates Eftekhari with Scripps Research and describes expertise in biomaterials and product development. [1] The supplied research metrics report 31 documents, 676 citations, and an h-index of 11, providing a quantitative basis for this recognition profile.

Keywords

Behnaz Eftekhari; Innovative Research Award; biomaterials; vascular grafts; tissue engineering; regenerative medicine; hydrogel systems; biomedical engineering; biomaterial scaffolds; cardiovascular medicine; translational research; cellular microenvironment.

Introduction

Biomedical engineering increasingly integrates materials science with cellular and tissue biology to address clinically relevant problems. Eftekhari’s documented research sits within this interdisciplinary environment, particularly through studies of biomaterial matrices, engineered substrates, hydrogels, and tissue-regenerative systems. Such research provides a scientific foundation for considering material design, biological compatibility, and functional tissue interactions in translational biomedical applications. [2]

Research Profile

Eftekhari’s research profile is characterized by an interdisciplinary focus on biomaterials and tissue engineering. Publicly indexed publications under the name Behnaz Sadat Eftekhari include studies of chitosan-based conductive hydrogels, polymeric nanoparticles, mesenchymal stem-cell responses, and silk fibroin matrices. [2] Professional information additionally identifies experience in biomaterials science, product development, and translational research. [1]

Research Contributions

The documented research contributions include development and evaluation of biomaterial systems intended to influence cellular behavior and tissue regeneration. Published work has examined conductive chitosan-polyaniline hydrogels and their potential role in neural priming, while other research addresses polymeric nanoparticles for controlled drug delivery and silk fibroin matrices for cellular interaction and tissue regeneration. [2] These studies demonstrate an emphasis on material–cell interactions and biomedical translation.

Publications

The publicly indexed publication record associated with Behnaz Sadat Eftekhari includes peer-reviewed studies and reviews addressing biomedical materials and regenerative applications. Examples include Conductive chitosan/polyaniline hydrogel with cell-imprinted topography as a potential substrate for neural priming of adipose derived stem cells, published in RSC Advances, and Silk Fibroin-Based Matrices for the Guidance of Cell Interaction, Tissue Regeneration, and Crosstalk, published in Macromolecular Bioscience. [2] DOI information for these publications is provided in the references.

Research Impact

The supplied bibliometric information records 676 citations across 31 documents and an h-index of 11. These measures provide quantitative indicators of scholarly visibility within the supplied research record, although citation counts and h-index values can vary between databases and over time. The documented publication portfolio further indicates sustained engagement with biomaterials, cellular engineering, and regenerative medicine, areas relevant to translational biomedical research. [1]

Award Suitability

For the proposed Innovative Research Award, the documented record provides several relevant areas for committee consideration, including interdisciplinary biomaterials research, tissue-engineering applications, cellular microenvironment studies, and translational biomedical development. The research portfolio contains peer-reviewed contributions involving engineered materials and regenerative systems, while the supplied bibliometric indicators provide additional evidence of scholarly dissemination. Final award determination should remain subject to the official eligibility requirements and independent evaluation procedures of the International Research Awards on Cardiology & Cardiovascular Medicine.

Conclusion

Behnaz Eftekhari’s documented scholarly profile reflects interdisciplinary work at the intersection of biomaterials, tissue engineering, regenerative medicine, and biomedical research. Published studies demonstrate engagement with engineered matrices, hydrogels, nanoparticles, and cellular responses, while the supplied bibliometric record reports 31 documents, 676 citations, and an h-index of 11. Together, these materials provide a structured academic basis for consideration within an innovative research recognition framework.

References

  1. Elsevier. (n.d.). Scopus author details: Behnaz Eftekhari, Author ID 57198443389. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57198443389
  2. Review article (2026). Functionalization of graphene oxide and its applications in tissue engineering and regenerative medicine.
    https://doi.org/10.1016/j.bioadv.2025.214421
  3. World Health Organization. (2026 ). Cardiovascular diseases. World Health Organization.
    https://cardiology-conferences.pencis.com/

Radwa Mehanna | Cardiovascular Researches | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Best Researcher Award

Radwa Mehanna — Alexandria University, Egypt
Radwa Mehanna
Affiliation Alexandria University
Country Egypt
Scopus ID 55851530300
Documents 43
Citations 927
h-index 19
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-9048-4464

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose scholarly work connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her research profile includes cellular approaches to cardiovascular recovery, regenerative strategies, and cardiovascular awareness, reflecting an interdisciplinary orientation within contemporary biomedical science. Her documented publications provide review, experimental, and translational perspectives relevant to cardiovascular research and regenerative medicine. [3]

Abstract

Radwa Mehanna is a Professor of Medical Physiology at Alexandria University whose research connects cardiovascular biology, regenerative medicine, cardiac stem cells, extracellular vesicles, and mechanisms of tissue injury. Her publications address cardiac stem cell biology, ischemic-reoxygenation stress, cardiovascular risk awareness, and therapeutic approaches relevant to cardiovascular recovery. Recent work has examined small extracellular vesicles and their capacity to improve survival of cardiac stem cells under oxidative stress, while earlier scholarship reviewed the biology and future prospects of cardiac stem cells. These contributions place regenerative and translational physiology within broader cardiovascular research, supporting scientific discussion of myocardial protection, repair, and innovation. [4]

Keywords

Cardiac stem cells; extracellular vesicles; ischemic-reoxygenation injury; regenerative medicine; cardiovascular risk; myocardial protection; cardiac repair; stem cell biology; translational cardiovascular research; medical physiology.

Introduction

Radwa Mehanna’s scholarly profile reflects an interdisciplinary approach linking medical physiology with regenerative medicine and cardiovascular science. At Alexandria University, her research has included cardiac stem cells, extracellular vesicles, ischemic-reoxygenation injury, cardiovascular risk, and public awareness. Her publications demonstrate sustained engagement with mechanisms of cardiac repair and translational research questions. [1][2]

Research Profile

Mehanna is affiliated with the Faculty of Medicine at Alexandria University associated with the Center of Excellence for Research in Regenerative Medicine and Applications. Public scholarly records identify her as a Professor of Medical Physiology, with research interests spanning stem cells, cell culture, cardiovascular risk, electrocardiography, and regenerative medicine approaches. [1]

Research Contributions

Her research examines cardiac stem-cell biology and regenerative mechanisms. Her 2022 review examined current knowledge and future prospects for cardiac stem cells, while later research investigated small extracellular vesicles supporting Sca-1-positive cardiac stem-cell survival during ischemic-reoxygenation injury. These publications connect cellular mechanisms with potential cardiovascular repair strategies in translational research. [2][3]

Publications

Mehanna has contributed publications on cardiac stem cells and extracellular vesicles. Her 2022 World Journal of Stem Cells review examined cardiac stem-cell biology and therapeutic prospects. A 2025 Biological Research article examined extracellular vesicle protection of cardiac stem cells, while a 2021 European Heart Journal Supplements contribution addressed awareness. [2][3]

Research Impact

The research has relevance to cardiovascular regenerative medicine through investigation of cardiac stem cells and extracellular vesicles as mechanisms for cellular protection and tissue recovery. Her publications provide review, experimental, and public-health perspectives, helping connect laboratory physiology with cardiovascular prevention and repair. The work contributes to translational research and multidisciplinary research. [2][3][4]

Award Suitability

Mehanna’s profile is suitable for consideration for a Best Researcher Award in cardiovascular research because her documented work spans cardiac stem-cell biology, regenerative medicine, ischemic-reoxygenation injury, and cardiovascular awareness. Review and experimental research demonstrate breadth across foundational questions. Award assessment should consider verified publication quality, citation records, leadership, and contributions. [1][2]

Conclusion

Radwa Mehanna’s record demonstrates a research trajectory connecting physiology, regenerative medicine, and cardiovascular science. Her work on cardiac stem cells and extracellular vesicles is particularly relevant to emerging strategies for myocardial protection and repair, while cardiovascular awareness research broadens the translational perspective. Her documented contributions provide a basis for recognition. [2][3][4]

References

  1. Egyptian Society of Extracellular Vesicles. (n.d.). Prof. Radwa Mehanna: Board profile and biography. Egyptian Society of Extracellular Vesicles.
    https://esev-eg.org/board/
  2. Mehanna, R. A., et al. (2022). Cardiac stem cells: Current knowledge and future prospects. World Journal of Stem Cells, 14(1), 1–40.
    https://doi.org/10.4252/wjsc.v14.i1.1
  3. Mehanna, R. A., et al. (2025). Small extracellular vesicles enhance the survival of Sca-1+ cardiac stem cells against ROS-induced ischemic-reoxygenation injury in vitro. Biological Research, 58, 12.
    https://doi.org/10.1186/s40659-025-00593-7
  4. Mehanna, R. (2021). Role of Awareness Activities in Mega-Events. European Heart Journal Supplements, 23(Supplement_D), suab069.019.
    https://doi.org/10.1093/eurheartj/suab069.019
  5. Barachini, S., Ghelardoni, S., Varga, Z. V., Mehanna, R. A., et al. (2023). Antineoplastic drugs inducing cardiac and vascular toxicity — An update. Vascular Pharmacology, 153, 107223.
    https://doi.org/10.1016/j.vph.2023.107223

Zhi-Hui Zhu | Cardiovascular Researches | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Zhi-Hui Zhu
Zhejiang University, China
Zhi-Hui Zhu
Affiliation Zhejiang University
Country China
Scopus ID 57199280440
Documents 4
Citations 73
h-index 3
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine

The Innovative Research Award recognizes scholarly achievements that have contributed to the advancement of biomedical and life science research. Zhi-Hui Zhu of Zhejiang University has developed a research profile characterized by investigations into liver development, regenerative biology, molecular genetics, and experimental disease modeling. Through studies employing zebrafish and mammalian systems, Zhu has contributed to understanding developmental regulation, tissue regeneration, and cellular lineage mechanisms relevant to human health and disease.[1] The body of work demonstrates interdisciplinary integration of genetics, developmental biology, and translational biomedical research, providing a foundation for future applications in regenerative medicine and cardiovascular-related biological investigations.[2]

Abstract

This article summarizes the scientific contributions of Zhi-Hui Zhu in developmental biology and regenerative research. The documented publications explore liver organogenesis, gene regulation, tissue regeneration, and transgenic model development. Collectively, these studies have contributed to understanding molecular pathways that govern organ formation and repair, providing insights applicable to broader biomedical and cardiovascular research contexts.[3]

Keywords

Developmental biology; Regenerative medicine; Zebrafish genetics; Liver development; Molecular signaling; Tissue regeneration; Functional genomics; Biomedical research.

Introduction

Modern biomedical research increasingly relies on model organisms to uncover mechanisms underlying organ development and disease progression. Zhu’s investigations have focused on genetic and cellular pathways involved in liver biology, utilizing zebrafish and mammalian systems to evaluate developmental processes and regenerative responses. These studies provide mechanistic evidence supporting the role of specific genes and signaling networks in maintaining tissue integrity and recovery following injury.[1][3]

Research Profile

Affiliated with Zhejiang University, Zhi-Hui Zhu has authored and co-authored peer-reviewed publications indexed in major scientific databases. The available metrics indicate four indexed documents, seventy-three citations, and an h-index of three. Research themes encompass developmental genetics, liver biology, transgenic technologies, and regenerative mechanisms, reflecting a consistent commitment to experimentally driven biological inquiry.[1]

Research Contributions

Among Zhu’s notable contributions is the characterization of liver-enriched gene family members essential for normal liver development in zebrafish, expanding knowledge of organogenesis and developmental regulation.[2] Additional investigations examined expression patterns of homologous genes in mammalian systems, providing comparative biological insights.[3] Research on Def haploinsufficiency demonstrated activation of p53-dependent TGFβ signaling during regenerative responses, revealing mechanisms associated with scar formation following partial hepatectomy.[4] Zhu also contributed to transgenic zebrafish methodologies supporting functional genomic analysis of candidate genes involved in tumor pathogenesis.[5]

Publications

  • Chang CQ et al. (2011). Liver-enriched gene 1a and 1b encode novel secretory proteins essential for normal liver development in zebrafish.
  • Zhu ZH et al. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse.
  • Zhu ZH et al. (2014). Haploinsufficiency of Def activates p53-dependent TGFβ signalling and causes scar formation after partial hepatectomy.
  • Ung CY et al. (2015). Mosaic zebrafish transgenesis for functional genomic analysis of cooperative genes in tumor pathogenesis.
  • Gao C et al. (2018). Hepatocytes in a normal adult liver are derived solely from embryonic hepatocytes.

Research Impact

The research portfolio has contributed valuable evidence regarding developmental pathways, tissue regeneration, and cellular lineage tracing. These findings support broader scientific efforts aimed at understanding disease mechanisms and regenerative therapies. The citation record further indicates continued scholarly engagement with the published findings, particularly in developmental and translational biology disciplines.[1][6]

Award Suitability

Zhu’s record demonstrates sustained contributions to biological research through original investigations, methodological development, and collaborative scientific output. The integration of developmental genetics and regenerative biology aligns with the objectives of the International Research Awards on Cardiology & Cardiovascular Medicine, particularly where fundamental biological discoveries inform future therapeutic and translational applications.[5]

Conclusion

Zhi-Hui Zhu’s scholarly contributions reflect a focused research trajectory in developmental and regenerative biology. Through investigations involving gene regulation, organ development, and cellular regeneration, the researcher has advanced scientific understanding of biological processes relevant to health and disease. The documented body of work provides a credible basis for recognition through an academic research award program.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Zhi-Hui Zhu, Author ID 57199280440. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57199280440
  2. Chang CQ, Hu MJ, Zhu ZH, et al. (2011). Liver-enriched gene 1a and 1b Encode Novel Secretory Proteins Essential for Normal Liver Development in Zebrafish. PLoS ONE.
    https://doi.org/10.1371/journal.pone.0022910
  3. Zhu ZH, Hu MJ, Chang CQ, Peng JR. (2012). Analysis of expression pattern of zebrafish leg1 homologous gene mu-leg1 in mouse. Hereditas.
  4. Zhu ZH, Chen J, Xiong JW, Peng JR. (2014). Haploinsufficiency of Def Activates p53-Dependent TGFβ Signalling and Causes Scar Formation after Partial Hepatectomy. PLoS ONE.
    https://doi.org/10.1371/journal.pone.0096576
  5. Ung CY, Guo F, Zhang X, Zhu Z, Zhu S. (2015). Mosaic Zebrafish Transgenesis for Functional Genomic Analysis of Candidate Cooperative Genes in Tumor Pathogenesis. Journal of Visualized Experiments.
    https://doi.org/10.3791/52567
  6. Gao C, Zhu Z, Gao Y, et al. (2018). Hepatocytes in a Normal Adult Liver Are Derived Solely from the Embryonic Hepatocytes. Journal of Genetics and Genomics.
    https://doi.org/10.1016/j.jgg.2017.12.003

Ersilia Nigro | Cardiovascular Researches | Innovative Research Award

Published on by Cardiology and Cardiovascular Medicine

Innovative Research Award

Ersilia Nigro
Università della Campania Vanvitelli, Italy

Ersilia Nigro
Affiliation Università della Campania Vanvitelli
Country Italy
Scopus ID 57194323816
Documents 119
Citations 3,964
h-index 33
Subject Area Cardiovascular Researches
Event International Research Awards on Cardiology & Cardiovascular Medicine
ORCID 0000-0001-5637-1685

The Innovative Research Award recognizes the scholarly contributions of Ersilia Nigro, an Italian researcher affiliated with Università della Campania Vanvitelli, whose work has advanced knowledge in cardiovascular and metabolic sciences. Her interdisciplinary research explores adipokines, inflammatory biomarkers, exercise physiology, metabolic dysfunction, and lifestyle-related determinants of cardiovascular health. With an established publication record, a Scopus h-index of 33, and nearly four thousand citations, her investigations have contributed to translational approaches linking molecular mechanisms with clinical practice.[1]

Abstract

This article summarizes the scientific profile of Ersilia Nigro in relation to the Innovative Research Award. Her work integrates molecular cardiology, metabolism, and preventive medicine, emphasizing biomarkers associated with obesity, inflammation, exercise adaptation, and cardiovascular risk. Current research demonstrates sustained engagement with emerging topics including adiponectin signaling, orexin regulation, muscle wasting, and cardiometabolic interventions.[2]

Keywords

Cardiovascular research; adipokines; exercise physiology; obesity; inflammation; cardiometabolic health; translational medicine; biomarkers.

Introduction

Contemporary cardiovascular science increasingly relies on multidisciplinary investigations connecting lifestyle behaviors with molecular pathways. Nigro’s research addresses this need by examining how exercise, nutrition, sleep, and metabolic dysfunction influence cardiovascular outcomes and chronic disease progression.[3]

Research Profile

Her publication portfolio spans clinical, translational, and experimental studies. Indexed in Scopus with 119 documents and 3,964 citations, her scholarship demonstrates sustained influence across cardiovascular medicine, endocrinology, and metabolic research. Collaborative investigations frequently examine biomarker-driven approaches to patient stratification and disease management.[1]

Research Contributions

  • Investigation of adiponectin isoforms and inflammatory biomarkers in chronic diseases.
  • Evaluation of exercise interventions and their effects on cardiometabolic health.
  • Analysis of lifestyle factors, including sleep and nutrition, in cardiovascular regulation.
  • Research on muscle wasting, dyslipidemia, and patient management strategies in chronic respiratory disorders.

Publications

Recent publications include studies on irisin responses in obese middle-aged males, exercise-induced modulation of adiponectin, orexin and lifestyle habits, COPD-associated muscle wasting, and inflammatory markers in Crohn’s disease.[4]

Research Impact

The impact of Nigro’s work is reflected in extensive citation activity and the adoption of biomarker-based approaches within cardiometabolic research. Her studies support evidence-informed strategies for prevention, risk assessment, and personalized interventions targeting obesity-related cardiovascular conditions.[5]

Award Suitability

The Innovative Research Award acknowledges scientific originality, interdisciplinary collaboration, and measurable influence. Nigro’s sustained contributions across cardiovascular medicine, molecular biology, and preventive health align with these criteria through a record of peer-reviewed outputs, translational relevance, and international visibility.[6]

Conclusion

Ersilia Nigro has established a significant research profile at the intersection of cardiovascular science and metabolism. Her investigations continue to inform understanding of biomolecular pathways underlying cardiometabolic disorders while advancing preventive and therapeutic perspectives relevant to contemporary healthcare challenges.

References

  1. Elsevier. (n.d.). Scopus author details: Ersilia Nigro, Author ID 57194323816. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57194323816
  2. Nigro, E., et al. (2026). Effects of Two Different Training Programs on Cardiometabolic Health, Body Composition and Irisin in Middle Age Obese Males: A Pilot Study. Life.
    DOI: https://doi.org/10.3390/life16040657
  3. Nigro, E., et al. (2025). Orexin and Lifestyle Habits: A Meaningful Connection Among Nutrition, Physical Activity, and Sleep Pattern in Health and Diseases. International Journal of Molecular Sciences.
    DOI: https://doi.org/10.3390/ijms26188980
  4. Nigro, E., et al. (2026). Acute Resistance Exercise Temporarily Reduces Circulating Adiponectin in Trained Young Men: A Pilot Study. Biomolecules. DOI: https://doi.org/10.3390/biom16020229
  5. Nigro, E., et al. (2025). Muscle Wasting and Treatment of Dyslipidemia in COPD: Implications for Patient Management. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13081817
  6. Nigro, E., et al. (2025). Adiponectin and HMW Oligomers in Relation to Inflammatory Markers in Crohn’s Disease Patients. Biomedicines.
    DOI: https://doi.org/10.3390/biomedicines13020273

Brian Morris | Hypertension | Best Academic Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Prof. Dr. Brian Morris | Hypertension | Best Academic Researcher Award

University Of Sydney | Australia

Professor Dr. Brian Morris is a highly respected biomedical scientist and Professor Emeritus at the School of Medical Sciences, University of Sydney, acclaimed for his groundbreaking research in molecular medical sciences, hypertension, and public health. Throughout his distinguished career, he has made substantial contributions to understanding the genetic and molecular foundations of cardiovascular disease and ageing. He has held several prominent academic positions, including Professor of Molecular Medical Sciences and Senior Lecturer in Physiology, and has provided influential leadership in organizing international scientific conferences, such as the first global meeting on the molecular genetics of hypertension. Professor Morris has also served on major national and international research committees, editorial boards, and review panels, and is recognized as an exceptional mentor whose students have gone on to achieve senior positions in academia and industry worldwide. His numerous honors and fellowships from prestigious organizations reflect his exceptional contributions to science and education. With a prolific publication record of 404 documents, his research has received 11,835 citations from 8,579 documents, achieving an h-index of 56. His studies, published in leading journals including Circulation, Nature Genetics, PNAS, and Hypertension, have influenced scientific thought globally. His pioneering patent for the first use of PCR in viral detection further underscores his lasting impact on molecular diagnostics. Through his scientific innovation, academic leadership, and lifelong dedication to advancing knowledge, Professor Morris has made enduring contributions to cardiovascular and molecular health research worldwide.

Profiles: Scopus | Orcid

Featured Publications

Sarman, G., Cox, G., & Morris, B. J. (2025). Critique of “The impact of foot reflexology on postoperative pain and fear in children following circumcision: A randomized controlled trial.” Journal of Pediatric Urology.

Cox, G., & Morris, B. J. (2025). Comments on Fendereski et al., Comparing penile problems in circumcised vs. uncircumcised boys: Insights from a large commercial claims database with a focus on provider type performing circumcision. Journal of Pediatric Surgery.

Chen, R., Donlon, T. A., Morris, B. J., Allsopp, R. C., Willcox, B. J., & Masaki, K. H. (2024). Association of alcohol with lung cancer risk in men with different growth hormone receptor genotypes. Lung Cancer.

Chen, R., Morris, B. J., Donlon, T. A., Nakagawa, K., Allsopp, R. C., Willcox, B. J., Masaki, K. H., & Lipsitz, L. A. (2024). FOXO3 longevity genotype mitigates risk posed by hypertension on incident coronary artery disease in middle-aged men: Kuakini Honolulu Heart Program. The Journals of Gerontology, Series A: Biological Sciences and Medical Sciences.

Morris, B. J., & Banerjee, J. (2024). Comment on ‘Changing relationships between HIV prevalence and circumcision in Lesotho’, and ‘Age-incidence and prevalence of HIV among intact and circumcised men: an analysis of PHIA surveys in Southern Africa’. Journal of Biosocial Science.

Morris, B. J., & Klausner, J. D. (2024). Detrimental to public health: Royal Australasian College of Physicians’ recent policy on infant circumcision. Pediatric Research.

Runze Wen | Cardiac Imaging | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Runze Wen | Cardiac Imaging | Best Researcher Award

The First Affiliated Hospital of University of Science and Technology | China

Dr. Runze Wen is an emerging scholar in the field of Cardiac Nuclear Medicine, currently pursuing his doctoral degree at the University of Science and Technology of China. His research focuses on advancing nuclear imaging techniques for cardiovascular diagnostics, with a strong emphasis on enhancing the precision and clinical applicability of cardiac assessments. Despite being at an early stage in his academic career, Dr. Wen has already demonstrated remarkable productivity and impact within the scientific community, with 3 published documents, 13 citations across 13 referencing works, and an h index of 3, a clear indication of the relevance and influence of his research. His investigations often integrate nuclear imaging modalities with innovative diagnostic approaches to improve the understanding of coronary microvascular dysfunction and other complex cardiac conditions. In addition to his academic achievements, Dr. Wen is a Fellow in Training (FIT) member of the American College of Cardiology (ACC), reflecting his commitment to professional development and international collaboration within the cardiology field. His ability to bridge advanced imaging science with clinical cardiology has earned him recognition as a promising young researcher dedicated to transforming cardiovascular diagnostics. Through his ongoing research and active engagement in academic circles, Dr. Runze Wen continues to contribute meaningfully to the future of nuclear cardiology, aiming to enhance patient care through evidence based innovation and interdisciplinary research excellence.

Profiles: Scopus | Orcid

Featured Publications

Wen, R., Xie, Q., Pan, B., Ni, M., Zhu, X., Meng, X., Wei, Z., Wu, X., Li, D., & Wang, X. (2025). Simultaneous 13N-ammonia and gadolinium perfusion using integrated PET–MRI: Diagnostic accuracy in coronary microvascular dysfunction. Frontiers in Medicine

Wen, R., Zhao, M., Chen, C., Yang, Y., & Zhang, B. (2023). A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate- and high-risk differentiated thyroid cancer patients: A bi-center retrospective study.

Yixin Xu | Cardiovascular Researches | Best Researcher Award 2025

Published on by Cardiology and Cardiovascular Medicine

Dr. Yixin Xu | Cardiovascular Researches | Best Researcher Award

The First Affiliated Hospital of Army Medical University | China

Author Profile

Orcid

Early Academic Pursuits

YiXin Xu began her medical journey at Xinjiang Medical University, where she pursued an undergraduate degree in Clinical Medicine. Her strong academic performance and dedication to patient care inspired her to continue postgraduate studies in Internal Medicine, specializing in cardiovascular medicine. This early pursuit of advanced knowledge built the foundation for her growing expertise in both clinical practice and research.

Professional Endeavors

Her professional development included an internship at the Traditional Chinese Medicine Hospital of Shapingba District in Chongqing City, where she gained valuable clinical exposure. She then undertook standardized resident physician training at the First Affiliated Hospital of Xinjiang Medical University. During this period, she successfully managed patient care, independently handled on-duty responsibilities, and developed expertise in treating conditions such as coronary heart disease, hypertension, and pulmonary hypertension.

Contributions And Research Focus

She has contributed to several important research projects that bridge clinical practice with scientific inquiry. These include investigating the relationship between vitamin D, parathyroid hormone, and circadian rhythms in blood pressure regulation among patients with hypertension. She also participated in the Step-Pre Project and the "iCare-Me" initiative, both of which aim to improve patient outcomes through innovative approaches. Additionally, she contributed to the creation of a predictive model for heart failure in patients with coronary heart disease, based on metabolic biomarkers, highlighting her focus on precision medicine and translational research.

Clinical Expertise

Through her training, she became proficient in both the theoretical and practical aspects of internal medicine. She is skilled in the standardized documentation of medical records, surgical notes, and disease course records. Her technical expertise includes performing essential clinical procedures such as abdominal puncture and bone marrow puncture. These abilities underscore her readiness to practice medicine at a high professional standard.

Impact And Influence

Her dual contributions as a clinician and researcher have positioned her to influence both patient care and the scientific community. By combining clinical experience with data-driven research, she advances understanding in cardiovascular disease while improving strategies for patient management. Her work reflects a commitment to bridging the gap between medical research and real-world healthcare delivery.

Academic Cites

Her scholarly contributions have been acknowledged through participation in collaborative studies and cited within ongoing cardiovascular research initiatives. These academic references reflect her growing influence and recognition within the medical research community.

Legacy And Future Contributions

Looking forward, she aspires to strengthen predictive models for cardiovascular disease and enhance evidence-based treatment protocols. Her career vision includes contributing to global medical research networks, publishing impactful studies, and advancing patient care practices through innovation and collaboration.

Conclusion

YiXin Xu exemplifies the qualities of a dedicated physician and researcher. With her academic excellence, clinical expertise, and meaningful research contributions, she is poised to make significant advancements in cardiovascular medicine. Her commitment to innovation and patient-centered care ensures that she will leave a lasting impact on both clinical practice and medical science.

Notable Publication

"Parathyroid hormone and vitamin D modulate nocturnal blood pressure dipping: a retrospective cohort study in primary hypertension"

Authors: Yixin Xu, Changjiang Deng, Xiaohui Liang
Journal: Clinical and Experimental Hypertension
Year: 2025

Dani Qin | Cardiovascular Disease | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Dani Qin | Cardiovascular Disease | Best Researcher Award

Yixing People's Hospital | China

Author Profiles

Scopus

Orcid

Early Academic Pursuits

Qin Dani began her academic journey with a strong foundation in pediatrics, completing her studies at a prestigious medical university and further pursuing advanced training. Her dedication to continuous learning is evident as she continues doctoral studies at a reputed university. Her academic background laid the groundwork for her clinical expertise and research orientation in pediatric healthcare.

Professional Endeavors

She has established herself as a key figure in the Department of Pediatrics at Yixing People's Hospital, where she has been contributing her expertise for many years. During her career, she also pursued advanced studies and training at well-regarded medical institutions, which broadened her clinical skills and enriched her professional development. She currently holds a leadership role as an Associate Chief Physician and plays an active part in pediatric development teams, shaping the direction of child healthcare services.

Contributions and Research Focus

Her clinical work spans the diagnosis and treatment of a wide spectrum of pediatric conditions, with particular strengths in infant and toddler health care, respiratory disorders, digestive system diseases, and neonatal health management. She has led several important research projects at provincial and municipal levels, demonstrating her commitment to bridging clinical practice with academic research. Her published works reflect a dedication to advancing pediatric medicine through evidence-based studies and practical insights.

Impact and Influence

Through her leadership and expertise, she has significantly contributed to improving pediatric care standards in her community and beyond. Her ability to manage both common and critical pediatric illnesses has earned her recognition among colleagues and institutions alike. Her influence extends to mentoring young professionals, thereby fostering the next generation of pediatric specialists.

Academic Cites

She has authored numerous academic publications in both international and national journals, with multiple contributions recognized in core and indexed platforms. Her scholarly work has been acknowledged through prestigious awards in natural science and academic excellence, showcasing her impact in both scientific and clinical communities.

Legacy and Future Contribution

Her career trajectory reflects a deep commitment to pediatric medicine, both in clinical practice and academic advancement. With her ongoing doctoral research, she is expected to make further strides in pediatric healthcare innovations. Her legacy will likely continue through her contributions to research, her role in nurturing young professionals, and her influence on public health standards in pediatrics.

Recognition and Honors

She has received several commendations from healthcare authorities and academic institutions for her outstanding contributions, including recognition for advanced individual achievements and excellence in academic publications. These accolades highlight her dedication, professionalism, and long-term impact in the medical field.

Conclusion

Qin Dani exemplifies the qualities of an accomplished physician, researcher, and academic leader. Her blend of clinical expertise, research achievements, and commitment to advancing pediatric medicine has left a lasting mark on both medical practice and scientific scholarship. With a proven record of excellence and continued pursuit of innovation, she stands as a role model in the field of pediatrics, poised to make even greater contributions in the years ahead.

Notable Publications

"Methionine sulfoxide suppresses adipogenic differentiation by regulating the mitogen‐activated protein kinase signaling pathway"

Authors: Dani Qin; Yong Lei; Wen Xie; Qiuju Zheng; Zhou Peng; Yiwen Liu; Biao Dai; Tieliang Ma; Ping
Journal: Cell Biology
Year: 2023

"Effects of miR-19b Overexpression on Proliferation, Differentiation, Apoptosis and Wnt/β-Catenin Signaling Pathway in P19 Cell Model of Cardiac Differentiation In Vitro"

Authors: Da-Ni Qin; Lingmei Qian; De-Liang Hu; Zhang-Bin Yu; Shu-Ping Han; Chun Zhu; Xuejie Wang;
Journal: Cell Biochemistry and Biophysics
Year: 2013

Fengxu Yu | Atrial Fibrillation | Best Researcher Award 

Published on by Cardiology and Cardiovascular Medicine

Fengxu Yu | Atrial Fibrillation | Best Researcher Award 

The Affiliated Hospital of Southwest Medical University | China

Author Profile:

Scopus

👨‍⚕️ MR. FENGXU YU – PIONEER IN CARDIOVASCULAR INNOVATION

🎓 EARLY ACADEMIC PURSUITS

Born in January 1976, Professor Fengxu Yu embarked on his medical journey with a strong academic foundation, earning his M.D. and later achieving qualifications as a doctoral supervisor. His passion for cardiovascular science led him to pursue postdoctoral training in France, equipping him with a global perspective and refined clinical research skills. This international exposure laid the groundwork for his future leadership in complex cardiovascular research and surgical practice.

💼 PROFESSIONAL ENDEAVORS

Currently serving as a Professor at The Affiliated Hospital of Southwest Medical University, Dr. Yu holds several distinguished roles:

  • Standing Committee Member, Cardiac Surgery Committee (CAMEA)

  • Committee Member, Heart Valve Committee (CRHA)

  • Vice Chair, Sichuan Thoracic & Cardiac Surgery Association

  • Academic Leader, recognized by the Sichuan Health Commission

  • Member, Asian Heart Valve Society, China Chapter

  • Recipient, Luzhou Top Talent Award

His consistent dedication has cemented his role as a leading figure in thoracic and cardiac surgery across China.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ATRIAL FIBRILLATION

Dr. Yu’s research endeavors focus on molecular and biomechanical mechanisms in cardiovascular disease, especially atrial fibrillation (AF), atherosclerosis, and aortic dissection. His current areas of exploration include:

  • Non-coding RNAs (e.g., circRNA/ceRNA networks) in AF pathogenesis

  • Application of induced pluripotent stem cells in modeling AF

  • Effects of shear stress on vascular endothelial health and its link to atherosclerosis

Through these efforts, Dr. Yu bridges basic science with clinical relevance, advancing the future of personalized medicine.

📊 IMPACT AND INFLUENCE

As a principal investigator, Dr. Yu has led nearly 20 major research projects funded by provincial and municipal institutions. He has also contributed to 30+ collaborative studies as a lead or co-investigator. His academic output includes over 50 peer-reviewed publications, with 12 articles indexed in SCI journals and 20+ papers in national core journals, showcasing his thought leadership in cardiovascular science.

📚 SELECTED RESEARCH PROJECTS

Some of Dr. Yu’s notable funded projects include:

  • Mechanism of Shear Stress-Downregulated Annexin A1 (2019)

  • circRNA-Regulated ceRNA Networks in AF (2025)

  • Personalized Warfarin Therapy Post-Valve Replacement (2022)

  • Hsa_circ_0025573—miR-133b—MMP9 in AF Pathogenesis (2022)

  • SRB1-Mediated Endothelial Injury in Atherosclerosis (2018)

These projects reflect a multidisciplinary approach to understanding and treating cardiovascular conditions.

🏅 ACADEMIC CITES AND MEMBERSHIPS

Professor Yu actively contributes to national and international academic bodies. His memberships include:

  • CAMEA – Cardiac Surgery Committee

  • CRHA – Heart Valve Committee

  • Sichuan Thoracic & Cardiac Surgery Association

  • Asian Heart Valve Society – China Chapter

These affiliations enhance his visibility in shaping future cardiac surgery standards and innovations.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Professor Fengxu Yu is a mentor, innovator, and academic leader. His mentorship of graduate students, collaboration with international institutions such as Heidelberg University, and continued work on translational research ensure a legacy of impactful science. As cardiovascular disease remains a global challenge, his pioneering work in non-coding RNA and biomechanical interactions is poised to redefine prevention and treatment strategies.

📑 NOTABLE PUBLICATIONS

"Myocardial infarction serum preconditioning bone marrow mesenchymal stem cell-derived exosomes enhance anti-fibrosis in rat myocardial infarction hearts" 

Authors: Y., Gan, Yang , C., Wang, Changyi , R., Liao, Ruili , ... H., Liu, Hui , Y., Fu, Yong
Journal: Molecular and Cellular Biochemistry.
Year: 2025

"Identification of the optimal reference genes for atrial fibrillation model established by iPSC-derived atrial myocytes" 

Authors: L., Li, Lei , Z., Zhao, Zijuan , Z., Liu, Zihao , ... Y., Nie, Yongmei , F., Yu, Fengxu
Journal: BMC Genomics
Year: 2024

"Postoperative delirium prediction after cardiac surgery using machine learning models" 

Authors: T., Yang, Tan , H., Yang, Hai , Y., Liu, Yan , ... Y., Zhang, Ying , F., Yu, Fengxu
Journal: Computers in Biology and Medicine
Year: 2024

Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award

Published on by Cardiology and Cardiovascular Medicine

Dr. Xiaodi Tang | Cardiovascular Medicine | Best Researcher Award